U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula CH3FO2S
Molecular Weight 98.097
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of METHANESULFONYL FLUORIDE

SMILES

CS(F)(=O)=O

InChI

InChIKey=KNWQLFOXPQZGPX-UHFFFAOYSA-N
InChI=1S/CH3FO2S/c1-5(2,3)4/h1H3

HIDE SMILES / InChI

Molecular Formula CH3FO2S
Molecular Weight 98.097
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Methanesulfonyl fluoride (SNX 001), a very long-acting CNS-selective acetylcholinesterase inhibitor, was studied as a palliative treatment for senile dementia of the Alzheimer type. This drug successfully completed phase I clinical trials where it showed effectively enhance memory in patients with Alzheimer's disease. However, it appears that further studies were discontinued.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P22303|||Q53F46
Gene ID: 43.0
Gene Symbol: ACHE
Target Organism: Homo sapiens (Human)
PubMed

PubMed

TitleDatePubMed
Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancer.
2008-08-05
In utero methanesulfonyl fluoride differentially affects learning and maze performance in the absence of long-lasting cholinergic changes in the adult rat.
2008-02
Nonenzymatic functions of acetylcholinesterase splice variants in the developmental neurotoxicity of organophosphates: chlorpyrifos, chlorpyrifos oxon, and diazinon.
2007-01
Prenatal exposure to the acetylcholinesterase inhibitor methanesulfonyl fluoride alters forebrain morphology and gene expression.
2005-08-08
Methanesulfonyl fluoride, an acetylcholinesterase inhibitor, attenuates simple learning and memory deficits in ischemic rats.
2005-03-15
Acceleration of Drosophila melanogaster acetylcholinesterase methanesulfonylation: peripheral ligand D-tubocurarine enhances the affinity for small methanesulfonylfluoride.
2002-02-20
Patents

Patents

Sample Use Guides

In a randomized placebo-controlled phase I study, 3.6 mg, 7.2 mg or 10.8 mg methanesulfonyl fluoride (MSF) were then orally administered to 27 consenting healthy volunteers (aged 50 to 72 years).
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Mon Mar 31 17:49:22 GMT 2025
Edited
by admin
on Mon Mar 31 17:49:22 GMT 2025
Record UNII
9H250YYY0R
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
FUMETTE
Preferred Name English
METHANESULFONYL FLUORIDE
Systematic Name English
MESYL FLUORIDE
Systematic Name English
SNX-001
Code English
Code System Code Type Description
CAS
558-25-8
Created by admin on Mon Mar 31 17:49:22 GMT 2025 , Edited by admin on Mon Mar 31 17:49:22 GMT 2025
PRIMARY
MESH
C005109
Created by admin on Mon Mar 31 17:49:22 GMT 2025 , Edited by admin on Mon Mar 31 17:49:22 GMT 2025
PRIMARY
PUBCHEM
11207
Created by admin on Mon Mar 31 17:49:22 GMT 2025 , Edited by admin on Mon Mar 31 17:49:22 GMT 2025
PRIMARY
EPA CompTox
DTXSID8060329
Created by admin on Mon Mar 31 17:49:22 GMT 2025 , Edited by admin on Mon Mar 31 17:49:22 GMT 2025
PRIMARY
WIKIPEDIA
METHANESULFONYL FLUORIDE
Created by admin on Mon Mar 31 17:49:22 GMT 2025 , Edited by admin on Mon Mar 31 17:49:22 GMT 2025
PRIMARY
DRUG BANK
DB13058
Created by admin on Mon Mar 31 17:49:22 GMT 2025 , Edited by admin on Mon Mar 31 17:49:22 GMT 2025
PRIMARY
FDA UNII
9H250YYY0R
Created by admin on Mon Mar 31 17:49:22 GMT 2025 , Edited by admin on Mon Mar 31 17:49:22 GMT 2025
PRIMARY
HSDB
6397
Created by admin on Mon Mar 31 17:49:22 GMT 2025 , Edited by admin on Mon Mar 31 17:49:22 GMT 2025
PRIMARY
ECHA (EC/EINECS)
209-192-2
Created by admin on Mon Mar 31 17:49:22 GMT 2025 , Edited by admin on Mon Mar 31 17:49:22 GMT 2025
PRIMARY